Acute and chronic treatment of L-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 3, 2008, Pages 469-472

  Ikehara, Osamu ^a   Kawasaki, Noriko ^a   Maezono, Katsumi ^a   Komatsu, Mitsuhisa ^b   Konishi, Atsushi ^a  

^a AJINOMOTO CO INC   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Glucose; Hypoglycemia; Insulin; L isoleucine

Indexed keywords

GLUCOSE; ISOLEUCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPOGLYCEMIA; INSULIN RELEASE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; ISOLEUCINE; MALE; MICE; MICE, INBRED C57BL; SUCROSE;

EID: 41149142315     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.469     Document Type: Article

References (14)

1. Tappy L., Acheson K., Normand S., Schneeberger D., Thelin A., Pachiaudi C., Riou J. P., Jequier E., Am. J. Physiol., 262, E826-833 (1992).
2. Tappy L., Acheson K., Normand S., Pachiaudi C., Jequier E., Riou J. P., Metabolism, 43, 428-434 (1994).
3. Doi M., Yamaoka I., Fukunaga T., Nakayama M., Biochem. Biophys. Res. Commun., 312, 1111-1117 (2003).
4. Nishitani S., Takehana K., Fujitani S., Sonaka I., Am. J. Physiol. Gastrointest. Liver Physiol., 288, G1292-G1300 (2005).
5. Zhang Y., Guo K., LeBlanc R. E., Loh D., Schwartz G. J., Yu Y. H., Diabetes, 56, 1647-1654 (2007).
6. Doi M., Yamaoka I., Nakayama M., Sugahara K., Yoshizawa F., Am. J. Physiol. Endocrinol. Metab., 292, E1683-E1693 (2007).
7. Winzell M. S., Ahren B., Diabetes, 53 (Suppl. 3), S215-S219 (2004).
8. Hu S., Wang S., Fanelli B., Bell P. A., Dunning B. E., Geisse S., Schmitz R., Boettcher B. R., J. Pharmacol. Exp. Ther., 293, 444-452 (2000).
9. Yamazaki K., Yasuda N., Inoue T., Yamamoto E., Sugaya Y., Nagakura T., Shinoda M., Clark R., Saeki T., Tanaka I., J. Pharmacol. Exp. Ther., 320, 738-746 (2007).
10. Gijsman H., Scarna A., Harmer C., McTavish S., Odontiadis J., Cowen P., Goodwin G., Psychopharmacology, 160, 192-197 (2002).
11. Sener A., Somers G., Devis G., Malaisse W. J., Diabetologia, 21, 135-142 (1981).
12. Sener A., Malaisse W. J., Eur. J. Clin. Invest., 11, 455-460 (1981).
13. Nishitani S., Ijichi C., Takehana K., Fujitani S., Sonaka I., Biochem. Biophys. Res. Commun., 313, 387-389 (2004).
14. Gallou-Kabani C., Vige A., Gross M. S., Rabes J. P., Boileau C., Larue-Achagiotis C., Tome D., Jais J. P., Junien C., Obesity (Silver Spring), 15, 1996-2005 (2007).